Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R de Groot

Showing results (481-490 of 568) with videos related to

Pageof 57
Sort By:
Journal of the American College of Cardiology|April 18, 2015
Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trialReinoud E Knops, Fleur V Y Tjong, Petr Neuzil, et al.
British Journal of Haematology|October 8, 2016
Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemiaJennifer M-L Tjon, Marco R de Groot, Saskia M A Sypkens Smit, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 17, 2023
Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patientsLinghe Wu, Zhu Jiang, Eva R Meulendijks, et al.
Bone Marrow Transplantation|April 7, 2021
Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantationMarjan Cruijsen, Jacobien R Hilberink, Walter J F M van der Velden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast CancerWolfgang J Janni, Brigitte Rack, Leon W M M Terstappen, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 13, 2018
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) studyRaffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
JACC. Clinical Electrophysiology|March 23, 2019
Additional Ganglion Plexus Ablation During Thoracoscopic Surgical Ablation of Advanced Atrial Fibrillation: Intermediate Follow-Up of the AFACT StudyWouter R Berger, Jolien Neefs, Nicoline W E van den Berg, et al.
Frontiers in Cardiovascular Medicine|March 19, 2025
Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillationEva R Meulendijks, Manouck J M Roelofs, Tim A C de Vries, et al.
JCI Insight|August 21, 2020
Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablationJasmeet S Reyat, Winnie Chua, Victor R Cardoso, et al.
International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.
Pageof 57

Showing results (481-490 of 568) with videos related to

Sort By:
Pageof 57
Journal of the American College of Cardiology|April 18, 2015
Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trialReinoud E Knops, Fleur V Y Tjong, Petr Neuzil, et al.
British Journal of Haematology|October 8, 2016
Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemiaJennifer M-L Tjon, Marco R de Groot, Saskia M A Sypkens Smit, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 17, 2023
Atrial inflammation and microvascular thrombogenicity are increased in deceased COVID-19 patientsLinghe Wu, Zhu Jiang, Eva R Meulendijks, et al.
Bone Marrow Transplantation|April 7, 2021
Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantationMarjan Cruijsen, Jacobien R Hilberink, Walter J F M van der Velden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast CancerWolfgang J Janni, Brigitte Rack, Leon W M M Terstappen, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 13, 2018
Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) studyRaffaele De Caterina, Peter Kelly, Pedro Monteiro, et al.
JACC. Clinical Electrophysiology|March 23, 2019
Additional Ganglion Plexus Ablation During Thoracoscopic Surgical Ablation of Advanced Atrial Fibrillation: Intermediate Follow-Up of the AFACT StudyWouter R Berger, Jolien Neefs, Nicoline W E van den Berg, et al.
Frontiers in Cardiovascular Medicine|March 19, 2025
Obese patients exhibit a greater enhancement in mental health-related quality of life compared to non-obese patients following thoracoscopic ablation of atrial fibrillationEva R Meulendijks, Manouck J M Roelofs, Tim A C de Vries, et al.
JCI Insight|August 21, 2020
Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablationJasmeet S Reyat, Winnie Chua, Victor R Cardoso, et al.
International Journal of Cardiology|May 2, 2024
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe studyPaulus Kirchhof, Ameet Bakhai, Carlo de Asmundis, et al.
Pageof 57